Cargando…

Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review

AIMS AND OBJECTIVES: Oral submucous fibrosis (OSMF) is known to be one of the most common premalignant conditions of the oral cavity. Areca nut (AN) is considered to be the disease’s primary cause, while there are other potential causes as well. However, routine clinical practice has revealed that n...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Sonia, Sandhu, Harman, Nadar, Karthick T, Ocampo Escobedo, Rosa L, Gupta, Radhika, Subbappa, Anitha, Bhullar, Harkaran S, Kaur, Manjinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202252/
https://www.ncbi.nlm.nih.gov/pubmed/37223447
http://dx.doi.org/10.4103/jispcd.JISPCD_229_22
_version_ 1785045402191396864
author Gupta, Sonia
Sandhu, Harman
Nadar, Karthick T
Ocampo Escobedo, Rosa L
Gupta, Radhika
Subbappa, Anitha
Bhullar, Harkaran S
Kaur, Manjinder
author_facet Gupta, Sonia
Sandhu, Harman
Nadar, Karthick T
Ocampo Escobedo, Rosa L
Gupta, Radhika
Subbappa, Anitha
Bhullar, Harkaran S
Kaur, Manjinder
author_sort Gupta, Sonia
collection PubMed
description AIMS AND OBJECTIVES: Oral submucous fibrosis (OSMF) is known to be one of the most common premalignant conditions of the oral cavity. Areca nut (AN) is considered to be the disease’s primary cause, while there are other potential causes as well. However, routine clinical practice has revealed that not all people who chew AN exhibit clinical signs of OSMF, and few people are reported to have it even without chewing AN. So, there must be other factors contributing to OSMF. Plasma fibrinogen degradation products (FDPs) have recently been discovered to be an early sign of this disease, indicating a potential link between the two. This review aims to examine the studies which have been published in the literature that explain the role of plasma FDPs in contributing to OSMF. MATERIALS AND METHODS: An electronic search of the published literature was performed without publication year limitation in PubMed/ Medline, Scopus, Google Scholar, Web of Science, Science Direct, Embase, and Research gate databases, using mesh keywords like (‘Oral submucous fibrosis’ OR ‘Oral submucous fibrosis’) AND (‘Fibrinogen degradation products’ OR ‘Plasma fibrinogen degradation products’) AND (‘Clinical grades’ OR ‘Histological grades’) AND (‘Diagnosis’). A manual search of all related journals was also done. We also referred to the reference lists of papers. The risk of bias was evaluated with the GRADE criteria (from the Grading of Recommendations Assessment, Development, and Evaluation Working Group). RESULTS: The search revealed a total of 12 relevant studies from 1979 to 2022. Nine out of 12 studies demonstrated the definite presence of plasma FDPs in such cases. CONCLUSIONS: Although the studies documented in the literature showing evidence of plasma FDPs in patients with OSMF are very few in number, their detection signifies an important clinical finding. More research is still required in this aspect to establish stronger evidence.
format Online
Article
Text
id pubmed-10202252
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-102022522023-05-23 Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review Gupta, Sonia Sandhu, Harman Nadar, Karthick T Ocampo Escobedo, Rosa L Gupta, Radhika Subbappa, Anitha Bhullar, Harkaran S Kaur, Manjinder J Int Soc Prev Community Dent Review Article AIMS AND OBJECTIVES: Oral submucous fibrosis (OSMF) is known to be one of the most common premalignant conditions of the oral cavity. Areca nut (AN) is considered to be the disease’s primary cause, while there are other potential causes as well. However, routine clinical practice has revealed that not all people who chew AN exhibit clinical signs of OSMF, and few people are reported to have it even without chewing AN. So, there must be other factors contributing to OSMF. Plasma fibrinogen degradation products (FDPs) have recently been discovered to be an early sign of this disease, indicating a potential link between the two. This review aims to examine the studies which have been published in the literature that explain the role of plasma FDPs in contributing to OSMF. MATERIALS AND METHODS: An electronic search of the published literature was performed without publication year limitation in PubMed/ Medline, Scopus, Google Scholar, Web of Science, Science Direct, Embase, and Research gate databases, using mesh keywords like (‘Oral submucous fibrosis’ OR ‘Oral submucous fibrosis’) AND (‘Fibrinogen degradation products’ OR ‘Plasma fibrinogen degradation products’) AND (‘Clinical grades’ OR ‘Histological grades’) AND (‘Diagnosis’). A manual search of all related journals was also done. We also referred to the reference lists of papers. The risk of bias was evaluated with the GRADE criteria (from the Grading of Recommendations Assessment, Development, and Evaluation Working Group). RESULTS: The search revealed a total of 12 relevant studies from 1979 to 2022. Nine out of 12 studies demonstrated the definite presence of plasma FDPs in such cases. CONCLUSIONS: Although the studies documented in the literature showing evidence of plasma FDPs in patients with OSMF are very few in number, their detection signifies an important clinical finding. More research is still required in this aspect to establish stronger evidence. Wolters Kluwer - Medknow 2023-04-28 /pmc/articles/PMC10202252/ /pubmed/37223447 http://dx.doi.org/10.4103/jispcd.JISPCD_229_22 Text en Copyright: © 2023 Journal of International Society of Preventive and Community Dentistry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Gupta, Sonia
Sandhu, Harman
Nadar, Karthick T
Ocampo Escobedo, Rosa L
Gupta, Radhika
Subbappa, Anitha
Bhullar, Harkaran S
Kaur, Manjinder
Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review
title Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review
title_full Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review
title_fullStr Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review
title_full_unstemmed Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review
title_short Plasma Fibrinogen Degradation Products as the Nonsurgical Diagnostic Tool for Oral Submucous Fibrosis: A Systematic Review
title_sort plasma fibrinogen degradation products as the nonsurgical diagnostic tool for oral submucous fibrosis: a systematic review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202252/
https://www.ncbi.nlm.nih.gov/pubmed/37223447
http://dx.doi.org/10.4103/jispcd.JISPCD_229_22
work_keys_str_mv AT guptasonia plasmafibrinogendegradationproductsasthenonsurgicaldiagnostictoolfororalsubmucousfibrosisasystematicreview
AT sandhuharman plasmafibrinogendegradationproductsasthenonsurgicaldiagnostictoolfororalsubmucousfibrosisasystematicreview
AT nadarkarthickt plasmafibrinogendegradationproductsasthenonsurgicaldiagnostictoolfororalsubmucousfibrosisasystematicreview
AT ocampoescobedorosal plasmafibrinogendegradationproductsasthenonsurgicaldiagnostictoolfororalsubmucousfibrosisasystematicreview
AT guptaradhika plasmafibrinogendegradationproductsasthenonsurgicaldiagnostictoolfororalsubmucousfibrosisasystematicreview
AT subbappaanitha plasmafibrinogendegradationproductsasthenonsurgicaldiagnostictoolfororalsubmucousfibrosisasystematicreview
AT bhullarharkarans plasmafibrinogendegradationproductsasthenonsurgicaldiagnostictoolfororalsubmucousfibrosisasystematicreview
AT kaurmanjinder plasmafibrinogendegradationproductsasthenonsurgicaldiagnostictoolfororalsubmucousfibrosisasystematicreview